Myocardin-related transcription factor A (MRTF-A) is a crucial regulator of gene expression involved in diverse cellular processes such as cell migration, cytoskeletal dynamics, and tissue development. Functionally, MRTF-A acts as a transcriptional coactivator by interacting with serum response factor (SRF) to promote the expression of target genes containing SRF-responsive elements. MRTF-A regulates the transcription of genes encoding cytoskeletal proteins, including actin and myosin isoforms, which are essential for cellular morphology, motility, and contractility.
Activation of MRTF-A involves complex regulatory mechanisms orchestrated by various signaling pathways, particularly those involving the Rho GTPase family and actin dynamics. In response to extracellular stimuli such as growth factors, mechanical stress, or changes in cell adhesion, Rho GTPases, particularly RhoA, activate downstream effectors such as Rho-associated protein kinases (ROCKs) and diaphanous-related formins (DRFs). These effectors phosphorylate and inhibit MRTF-A's interaction with actin monomers, promoting its nuclear translocation and association with SRF to activate gene transcription. Additionally, MRTF-A activation can be modulated by actin dynamics, as changes in actin polymerization status affect the availability of G-actin, which binds and sequesters MRTF-A in the cytoplasm. Furthermore, signaling pathways such as the integrin-mediated focal adhesion complex and mechanotransduction pathways influence MRTF-A activity by regulating actin dynamics and cytoskeletal tension. Overall, elucidating the intricate mechanisms governing MRTF-A activation provides valuable insights into its role in cellular physiology and its implications in various physiological and pathological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is a selective Arp2/3 complex inhibitor that indirectly activates MRTF-A. By inhibiting actin polymerization, it disrupts the RhoA/actin/MRTF-A pathway, leading to the release of MRTF-A from cytoplasmic retention and its subsequent activation in the nucleus. | ||||||
CK-869 | 388592-44-7 | sc-507274 | 5 mg | $163.00 | ||
CK-869 is a selective Arp2/3 complex inhibitor that indirectly activates MRTF-A. Similar to CK-666, it disrupts actin polymerization, leading to the release of MRTF-A from cytoplasmic retention and its subsequent activation in the nucleus. | ||||||